Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

After allogeneic hematopoietic stem cell transplantation (allo-HSCT), acute leukemia relapse is common, and asymmetric bone marrow recurrence hasn't been reported. Because the anatomical distribution of acute leukemia clones in the bone marrow after allo-HSCT is presumed to be diffuse, bone mar...

Full description

Bibliographic Details
Main Authors: Han Yan, Zhenyang Zhou, Yingying Wu, Zhaodong Zhong, Yong You, Junxia Yao, Wanxin Chen, Linghui Xia, Xiaotian Xia, Wei Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.626018/full
id doaj-23b89d9f4d3e4840afa1908fa529653b
record_format Article
spelling doaj-23b89d9f4d3e4840afa1908fa529653b2021-03-04T08:20:15ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.626018626018Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationHan Yan0Zhenyang Zhou1Zhenyang Zhou2Yingying Wu3Zhaodong Zhong4Yong You5Junxia Yao6Wanxin Chen7Linghui Xia8Xiaotian Xia9Wei Shi10Wei Shi11Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Province Key Laboratory of Molecular Imaging, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaFred Hutchinson Cancer Research Center, Seattle, WA, United StatesAfter allogeneic hematopoietic stem cell transplantation (allo-HSCT), acute leukemia relapse is common, and asymmetric bone marrow recurrence hasn't been reported. Because the anatomical distribution of acute leukemia clones in the bone marrow after allo-HSCT is presumed to be diffuse, bone marrow aspirations are performed in single site. The first case was a 20-year-old man who was diagnosed with acute myelomonocytic leukemia and received haploidentical allo-HSCT. Routine bone marrow biopsy of his left posterior iliac bone marrow showed 52% leukemia blasts, while the right side had 0% blasts 10 days later. The second case was a 23-year-old woman who was diagnosed with acute B lymphoblastic leukemia and received HLA-identical sibling allo-HSCT. Although 62% of blasts were found in her left iliac marrow on day +122, 0% of blasts were found on a sample obtained from the right iliac crest on day +128. Bilateral iliac bone marrow pathology and whole-body 18F-FDG PET/CT scans confirmed that the leukemic infiltration in her bone marrow was asymmetric. To our knowledge, these are the first case reports of asymmetric bone marrow infiltration of blasts in acute leukemia patients after allo-HSCT. Bilateral posterior iliac crest aspirations or 18F-FDG-PET/CT scans may help distinguish such involvement.https://www.frontiersin.org/articles/10.3389/fonc.2021.626018/fullasymmetricblastsrelapseacute leukemiaallogeneic hematopoietic stem cell transplantation18F-FDG-PET/CT
collection DOAJ
language English
format Article
sources DOAJ
author Han Yan
Zhenyang Zhou
Zhenyang Zhou
Yingying Wu
Zhaodong Zhong
Yong You
Junxia Yao
Wanxin Chen
Linghui Xia
Xiaotian Xia
Wei Shi
Wei Shi
spellingShingle Han Yan
Zhenyang Zhou
Zhenyang Zhou
Yingying Wu
Zhaodong Zhong
Yong You
Junxia Yao
Wanxin Chen
Linghui Xia
Xiaotian Xia
Wei Shi
Wei Shi
Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Frontiers in Oncology
asymmetric
blasts
relapse
acute leukemia
allogeneic hematopoietic stem cell transplantation
18F-FDG-PET/CT
author_facet Han Yan
Zhenyang Zhou
Zhenyang Zhou
Yingying Wu
Zhaodong Zhong
Yong You
Junxia Yao
Wanxin Chen
Linghui Xia
Xiaotian Xia
Wei Shi
Wei Shi
author_sort Han Yan
title Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
title_short Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
title_full Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
title_fullStr Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
title_full_unstemmed Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
title_sort case report: asymmetric bone marrow involvement in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-03-01
description After allogeneic hematopoietic stem cell transplantation (allo-HSCT), acute leukemia relapse is common, and asymmetric bone marrow recurrence hasn't been reported. Because the anatomical distribution of acute leukemia clones in the bone marrow after allo-HSCT is presumed to be diffuse, bone marrow aspirations are performed in single site. The first case was a 20-year-old man who was diagnosed with acute myelomonocytic leukemia and received haploidentical allo-HSCT. Routine bone marrow biopsy of his left posterior iliac bone marrow showed 52% leukemia blasts, while the right side had 0% blasts 10 days later. The second case was a 23-year-old woman who was diagnosed with acute B lymphoblastic leukemia and received HLA-identical sibling allo-HSCT. Although 62% of blasts were found in her left iliac marrow on day +122, 0% of blasts were found on a sample obtained from the right iliac crest on day +128. Bilateral iliac bone marrow pathology and whole-body 18F-FDG PET/CT scans confirmed that the leukemic infiltration in her bone marrow was asymmetric. To our knowledge, these are the first case reports of asymmetric bone marrow infiltration of blasts in acute leukemia patients after allo-HSCT. Bilateral posterior iliac crest aspirations or 18F-FDG-PET/CT scans may help distinguish such involvement.
topic asymmetric
blasts
relapse
acute leukemia
allogeneic hematopoietic stem cell transplantation
18F-FDG-PET/CT
url https://www.frontiersin.org/articles/10.3389/fonc.2021.626018/full
work_keys_str_mv AT hanyan casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT zhenyangzhou casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT zhenyangzhou casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT yingyingwu casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT zhaodongzhong casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT yongyou casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT junxiayao casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT wanxinchen casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT linghuixia casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT xiaotianxia casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT weishi casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
AT weishi casereportasymmetricbonemarrowinvolvementinpatientswithacuteleukemiaafterallogeneichematopoieticstemcelltransplantation
_version_ 1724232109210468352